NASDAQ · Shell Companies · USD

Frazier Life Sciences Acquisition Corp II (FLSC) Stock Analysis

Frazier Life Sciences Acquisition Corp II (FLSC) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

FLSC

$10.30

+$0.02 (+0.19%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare FLSC with… →

FLSC Key Statistics

As of Oct 21, 2026

Trading

Open: $10.30
Previous Close: $10.28
Day's Range: 10.28–10.37
52-Week Range: 10.18–10.63
Volume: 45.15K

Valuation

Market Cap: $99.65M

Financials (FY)

Shares Outstanding: 7.80M

Dividend and dates

Avg Volume: 313.52K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Frazier Life Sciences Acquisition Corp II (FLSC) has a market capitalization of $99.65M.

Analysis

Data-derived

Company Overview

The market values Frazier Life Sciences Acquisition Corp II (FLSC) at $99.65M. The company sits in the Financial Services sector, in the Shell Companies industry.

The most recent close on file for FLSC is $10.30, dated October 21, 2026. That is +$0.02 (+0.19%) against the previous close. The 52-week range on file runs from $10.18 to $10.63. The latest close sits 1.18% above that 52-week low.

Growth & Income

No dividend is on file for FLSC.

So far in 2026 the total return is +0.10%.

Peer Comparison

Frazier Life Sciences Acquisition Corp II (FLSC) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Frazier Life Sciences Acquisition Corp II	FLSC	$99.65M	—
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Frazier Life Sciences Acquisition Corp II has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$596.26M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Frazier Life Sciences Acquisition Corp II

Frazier Life Sciences Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.